MaxCyte, Inc. Increase (Decrease) in Inventories
MaxCyte, Inc. (MXCT) reported Increase (Decrease) in Inventories of $852.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-13
- MaxCyte, Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was $472.00K.
- MaxCyte, Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was $380.00K.
- MaxCyte, Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was $72.00K.
- MaxCyte, Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was $107.00K.
- MaxCyte, Inc. increase (decrease) in inventories for fiscal 2025 was -$575.00K.
- MaxCyte, Inc. increase (decrease) in inventories for fiscal 2024 was -$1.36M, a 130.04% decline from fiscal 2023.
- MaxCyte, Inc. increase (decrease) in inventories for fiscal 2023 was $4.53M, a 29.80% increase from fiscal 2022.
- MaxCyte, Inc. increase (decrease) in inventories for fiscal 2022 was $3.49M, a 148.47% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $472.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $852.00K 10-Q · filed 2026-08-13 | $924.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.03M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | $380.00K 10-Q · filed 2026-05-13 | $452.00K derived: sum of 2 quarters · filed 2026-05-13 | $559.00K derived: sum of 3 quarters · filed 2026-05-13 | $336.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $179.00K derived: sum of 2 quarters · filed 2026-03-25 | -$44.00K derived: sum of 3 quarters · filed 2026-08-13 | -$575.00K 10-K · filed 2026-03-25 | |||
| 2025-09-30 | $107.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$116.00K derived: sum of 2 quarters · filed 2026-08-13 | -$647.00K 10-Q · filed 2025-11-13 | -$1.17M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | -$223.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$754.00K 10-Q · filed 2026-08-13 | -$1.28M derived: sum of 3 quarters · filed 2026-08-13 | -$1.28M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | -$531.00K 10-Q · filed 2026-05-13 | -$1.06M derived: sum of 2 quarters · filed 2026-05-13 | -$1.06M derived: sum of 3 quarters · filed 2026-05-13 | -$1.72M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | -$527.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$529.00K derived: sum of 2 quarters · filed 2026-03-25 | -$1.19M derived: sum of 3 quarters · filed 2026-03-25 | -$1.36M 10-K · filed 2026-03-25 | |||
| 2024-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$666.00K derived: sum of 2 quarters · filed 2025-11-13 | -$835.00K 10-Q · filed 2025-11-13 | -$389.00K derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | -$664.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$833.00K 10-Q · filed 2025-08-06 | -$387.00K derived: sum of 3 quarters · filed 2025-08-06 | $1.16M derived: sum of 4 quarters · filed 2025-08-06 | |||
| 2024-03-31 | -$169.00K 10-Q · filed 2025-05-08 | $277.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.82M derived: sum of 3 quarters · filed 2025-05-08 | $2.66M derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | $446.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $1.99M derived: sum of 2 quarters · filed 2025-03-11 | $2.83M derived: sum of 3 quarters · filed 2025-03-11 | $4.53M 10-K · filed 2025-03-11 | |||
| 2023-09-30 | $1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $2.38M derived: sum of 2 quarters · filed 2024-11-06 | $4.09M 10-Q · filed 2024-11-06 | $4.09M 10-Q · filed 2023-11-08 | $4.70M derived: sum of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | $836.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $2.54M 10-Q · filed 2024-08-06 | $2.54M 10-Q · filed 2023-08-09 | $3.15M derived: sum of 3 quarters · filed 2024-08-06 | $3.40M derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | $1.71M 10-Q · filed 2024-05-07 | $2.32M derived: sum of 2 quarters · filed 2024-05-07 | $2.56M derived: sum of 3 quarters · filed 2024-05-07 | $3.82M derived: sum of 4 quarters · filed 2024-05-07 | |||
| 2022-12-31 | $612.30K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $853.50K derived: sum of 2 quarters · filed 2024-03-12 | $2.12M derived: sum of 3 quarters · filed 2024-03-12 | $3.49M 10-K · filed 2024-03-12 | $3.49M 10-K · filed 2023-03-15 | ||
| 2022-09-30 | $241.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.50M derived: sum of 2 quarters · filed 2023-11-08 | $2.88M 10-Q · filed 2023-11-08 | $3.99M derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $2.64M 10-Q · filed 2023-08-09 | $3.75M derived: sum of 3 quarters · filed 2023-08-09 | $3.86M derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | $1.38M 10-Q · filed 2023-05-10 | $2.48M derived: sum of 2 quarters · filed 2023-05-10 | $2.60M derived: sum of 3 quarters · filed 2023-05-10 | $2.49M derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $1.22M derived: sum of 2 quarters · filed 2023-03-15 | $1.12M derived: sum of 3 quarters · filed 2023-03-15 | $1.41M 10-K · filed 2023-03-15 | |||
| 2021-09-30 | $117.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $12.30K derived: sum of 2 quarters · filed 2022-11-09 | $300.20K 10-Q · filed 2022-11-09 | $408.60K derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2021-06-30 | -$105.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $182.30K 10-Q · filed 2022-08-10 | $290.70K derived: sum of 3 quarters · filed 2022-08-10 | $464.00K derived: sum of 4 quarters · filed 2022-08-10 | |||
| 2021-03-31 | $287.90K 10-Q · filed 2022-05-09 | $396.30K derived: sum of 2 quarters · filed 2022-05-09 | $569.60K derived: sum of 3 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | $108.40K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $281.70K derived: sum of 2 quarters · filed 2022-03-22 | $890.60K 10-K · filed 2022-03-22 | ||||
| 2020-09-30 | $173.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $782.20K 10-Q · filed 2021-11-10 | |||||
| 2020-06-30 | $608.90K 10-Q · filed 2021-09-13 | ||||||
| 2019-12-31 | $1.89M 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |